31st CCM/E Oversight Committee Meeting Reviews GC7 Grant PerformanceDate: 12 November 2026
The CCM/E Oversight Committee held its 31st meeting on 12 November 2026 to review the Period 9 performance of Global Fund GC7 grants for HIV, Tuberculosis (TB), Malaria, and Resilient and Sustainable Systems for Health (RSSH) for the reporting period July–September 2026.

Dr. Neghist Tesfaye – OC Chairperson

Mr. Abayneh Admas, Oversight and Compliance Officer
at the CCM/E Secretariat
The meeting brought together Oversight Committee members, Principal Recipients (PRs), Sub-Recipients (SRs), and relevant implementing partners to assess programmatic and financial performance, review implementation challenges, and identify corrective actions.
The review highlighted encouraging programmatic performance across the malaria, HIV, and TB and RSSH grants. However, concerns remained regarding low financial absorption, procurement delays, commodity shortages, regional performance disparities, and implementation challenges in conflict-affected areas, particularly Tigray. The RSSH grant also recorded low cumulative financial absorption of 43%.
Following the discussions, the Committee recommended key actions to strengthen grant implementation, address identified bottlenecks and enhance accountability. These include revising acceleration plans, expediting procurement and commodity distribution, ensuring timely budget disbursement, and regularly monitoring agreed corrective actions.
The meeting also agreed to conduct two Global Fund-specific oversight field visits annually in 2027, complemented by two additional visits integrated with other feasible programmes.
The Committee reaffirmed its commitment to strengthening oversight, addressing implementation bottlenecks, and ensuring the effective utilization of Global Fund resources to improve health outcomes in Ethiopia.